Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3366427 | 0.85 | HSD17B10 (0.46) | HSD17B10 | |
| SCHEMBL9891029 | 0.73 | — | — | |
| SCHEMBL12240886 | 0.72 | — | — | |
| SCHEMBL6092292 | 0.68 | CYP2C19 (0.36) | HSD17B10CYP1A2CYP2C19KMT2A | |
| SCHEMBL18557264 | 0.66 | — | — | |
| SCHEMBL5571544 | 0.65 | KMT2A (0.33) | CYP1A2CYP2D6CYP2C9CYP2C19KMT2A | |
| SCHEMBL15531853 | 0.65 | MEN1 (0.40) | KMT2A | |
| SCHEMBL13612712 | 0.64 | ALDH1A1 (0.38) | HSD17B10CYP1A2CYP2C9CYP2C19KMT2A | |
| SCHEMBL425266 | 0.63 | CNR2 (0.37) | HSD17B10CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL12608295 | 0.62 | CNR2 (0.34) | HSD17B10CYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220135525-A1 | Carbondisulfide Derived Zwitterions | DALY THOMAS (US) | 2022-05-05 | — | — | US | disclosed |
| US-10975027-B2 | Carbondisulfide derived zwitterions | DALY THOMAS (US) | 2021-04-13 | — | — | US | disclosed |
| US-20200331853-A1 | Carbondisulfide Derived Zwitterions | DALY THOMAS (US) | 2020-10-22 | — | — | US | disclosed |
| US-10696628-B2 | Carbondisulfide derived zwitterions | TPAT IP LLC (US) | 2020-06-30 | — | — | US | disclosed |
| US-20190233372-A1 | Carbondisulfide Derived Zwitterions | TPAT IP LLC | 2019-08-01 | — | — | US | disclosed |
| US-10259783-B2 | Carbondisulfide derived zwitterions | TPAT IP LLC | 2019-04-16 | — | — | US | disclosed |
| US-20170275248-A1 | Carbondisulfide Derived Zwitterions | TPAT IP LLC | 2017-09-28 | — | — | US | disclosed |
| US-9676709-B2 | Carbondisulfide derived zwitterions | TPAT IP LLC | 2017-06-13 | — | — | US | disclosed |
| US-20170129853-A1 | Carbondisulfide Derived Zwitterions | TPAT IP LLC | 2017-05-11 | — | — | US | disclosed |
| US-9580385-B2 | Carbondisulfide derived zwitterions | TPAT IP LLC | 2017-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170129853-A1 | Carbondisulfide Derived Zwitterions | SRM, PKD1, SLC7A11 | HSD17B10 4398/4885CYP1A2 4851/4885CYP2D6 4742/4885 |
| US-20170275248-A1 | Carbondisulfide Derived Zwitterions | SRM, PKD1, SLC7A11 | HSD17B10 4398/4885CYP1A2 4851/4885CYP2D6 4742/4885 |
| US-10259783-B2 | Carbondisulfide derived zwitterions | SRM, PKD1, SLC7A11 | HSD17B10 4398/4885CYP1A2 4851/4885CYP2D6 4742/4885 |
| US-20220135525-A1 | Carbondisulfide Derived Zwitterions | SRM, PKD1, SLC7A11 | HSD17B10 4398/4885CYP1A2 4851/4885CYP2D6 4742/4885 |
| US-20200331853-A1 | Carbondisulfide Derived Zwitterions | SRM, PKD1, SLC7A11 | HSD17B10 4398/4885CYP1A2 4851/4885CYP2D6 4742/4885 |
| US-10696628-B2 | Carbondisulfide derived zwitterions | SRM, PKD1, SLC7A11 | HSD17B10 4398/4885CYP1A2 4851/4885CYP2D6 4742/4885 |
| US-10975027-B2 | Carbondisulfide derived zwitterions | SRM, PKD1, SLC7A11 | HSD17B10 4398/4885CYP1A2 4851/4885CYP2D6 4742/4885 |
| US-20190233372-A1 | Carbondisulfide Derived Zwitterions | SRM, PKD1, SLC7A11 | HSD17B10 4398/4885CYP1A2 4851/4885CYP2D6 4742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.